Toxic erythema of chemotherapy
نویسندگان
چکیده
منابع مشابه
Chemotherapy-induced acral erythema.
Sir, Chemotherapy-induced acral erythema (CIAE) is a cytotoxic drug reaction to certain systemic chemotherapeutic agents, such as £uorouracil, doxorubicin, and especially cytosine arabinoside (1). Following discontinuation of chemotherapy, cutaneous lesions subside in 1 ^ 2 weeks with eventual desquamation. Rechallenge of patients with similar chemotherapeutic agents has reproduced the reaction...
متن کاملMalignant intertrigo: A subset of toxic erythema of chemotherapy requiring recognition
MI: malignant intertrigo PPE: palmoplantar erythrodysesthesia SDRIFE: symmetrical drug-related intertriginous, flexural exanthema TEC: toxic erythema of chemotherapy INTRODUCTION Toxic erythema of chemotherapy (TEC) encompasses a broad spectrum of cytotoxic effects on the skin. Despite increasing awareness of TEC, such eruptions may remain unrecognized and subsequently result in unnecessary hos...
متن کاملToxic erythema of the neonate Hidradenitis suppurativa
Toxic erythema of the neonate (erythema toxicum, erythema toxicum neonatorum) is a very common, self-limiting disorder that presents as an asymptomatic erythematous macular rash usually in the first few days of life. Very rarely, the eruption occurs a week or more after birth. It affects up to 50% of neonates. In survey studies from Japan, Australia, China and India, toxic erythema was found in...
متن کاملPalmar-plantar erythema associated with combination chemotherapy.
We report three cases of a distinctive palmar-plantar erythema associated with the treatment of non-Hodgkin's lymphoma and acute myeloid leukaemia. The rash is characterized by a painful, sharply demarcated, intense erythema of the palms and/or soles followed by bulla formation, desquamation and healing. The eruption is self limiting in nature and did not adversely affect prognosis. Treatment n...
متن کاملLong-term toxic effects of adjuvant chemotherapy in breast cancer.
Breast cancer is the most common malignant tumor affecting women. Adjuvant systemic therapies have been shown to have a significant impact on reducing the risk for breast cancer recurrence and overall mortality. Chemotherapy remains an important and frequently used treatment option in the adjuvant setting, and the associated short-term adverse events are very well described. However, there is i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: QJM: An International Journal of Medicine
سال: 2021
ISSN: 1460-2725,1460-2393
DOI: 10.1093/qjmed/hcab136